Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Hypertension

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ajh.2008.346PMID 19057516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two Cardiovascular Risk Factors in One? Homocysteine and Its Relation to Glomerular Filtration Rate

  2008cited by this paper
• The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio.

  2007cited by this paper
• Asymmetric Dimethylarginine in Cerebral Small Vessel Disease

  2007cited by this paper
• Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease

  2007cited by this paper
• Homocysteine and cerebral ischemia: pathogenic and therapeutical implications.

  2007cited by this paper
• Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway

  2007cited by this paper
• Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?

  2007cited by this paper
• Asymmetric dimethylarginine in homocystinuria due to cystathionine β-synthase deficiency: Relevance of renal function

  2006cited by this paper
• Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move.

  2006cited by this paper
• Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.

  2006cited by this paper
• ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans

  2006cited by this paper
• Salt Loading on Plasma Asymmetrical Dimethylarginine and the Protective Role of Potassium Supplement in Normotensive Salt-Sensitive Asians

  2006cited by this paper
• Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.

  2006cited by this paper
• Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease.

  2006cited by this paper
• Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.

  2006cited by this paper
• Total Homocysteine Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study

  2005cited by this paper
• Homocysteine and the kidney.

  2005cited by this paper
• Homocysteine and the kidney.

  2005cited by this paper
• Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance

  2005cited by this paper
• Endoscopic anatomy of the chordae willisii in the superior sagittal sinus.

  2004cited by this paper
• Serum Total Homocysteine Concentrations and Risk of Stroke and Its Subtypes in Japanese

  2004cited by this paper
• Correlation of NO Metabolites and 8-Iso-Prostaglandin F2a With Periventricular Hyperintensity Severity

  2004cited by this paper
• Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease

  2004cited by this paper
• Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway

  2004cited by this paper
• Correlation of NO metabolites and 8-iso-prostaglandin F2α with periventricular hyperintensity severity

  2004cited by this paper
• Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.

  2003cited by this paper
• Carotid Artery Stenosis in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation

  2002cited by this paper
• Evolution of White Matter Lesions

  2002cited by this paper
• T-786C Polymorphism in Endothelial NO Synthase Gene Affects Cerebral Circulation in Smokers: Possible Gene-Environmental Interaction

  2002cited by this paper
• Pathophysiology of Age-Related Cerebral White Matter Changes

  2002cited by this paper
• An automated analyzer for methylated arginines in rat plasma by high-performance liquid chromatography with post-column fluorescence reaction.

  2002cited by this paper
• Neuropathology of White Matter Lesions in Vascular Cognitive Impairment

  2002cited by this paper
• OBESITY AND ITS RELATIONSHIP TO MARITAL STATUS IN US ADULTS. RESULTS FROM THE THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1994

  2001cited by this paper
• Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.

  2001cited by this paper
• Elevated Plasma Homocysteine Levels and Risk of Silent Brain Infarction in Elderly People

  2001cited by this paper
• Angiotensinogen Gene Promoter Haplotype and Microangiopathy-Related Cerebral Damage: Results of the Austrian Stroke Prevention Study

  2001cited by this paper
• Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine

  2001cited by this paper
• Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine.

  2001cited by this paper
• Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.

  2000cited by this paper
• Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension : modulation of nitric oxide synthesis by salt intake.

  2000cited by this paper
• Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

  2000cited by this paper
• Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension.

  1999cited by this paper
• Effects of some guanidino compounds on human cerebral arteries.

  1999cited by this paper
• Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.

  1999cited by this paper
• Evaluation of genetic risk factors for silent brain infarction.

  1999cited by this paper
• Homocysteine and atherothrombosis.

  1998cited by this paper
• Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

  1998cited by this paper
• Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study.

  1997cited by this paper
• Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor.

  1996cited by this paper
• Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants.

  1996cited by this paper
• Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits.

  1996cited by this paper
• Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

  1995cited by this paper
• Nitric Oxide Synthase Inhibition and Cerebrovascular Regulation

  1994cited by this paper
• White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors.

  1988cited by this paper

• Pathogenetic mechanisms of development of small vessel disease of the brain

  2026cites this paper
• Biomarkers of Endothelial Dysfunction in Cerebral Small Vessel Disease.

  2026cites this paper
• Roles of neuroimaging markers and biomarkers in cerebral small vessel disease and their associations with cognitive function

  2025cites this paper
• Modern understanding of the pathogenetic mechanisms of small vessel disease

  2024cites this paper
• Asymmetric dimethylarginine induces maladaptive function of the blood-brain barrier

  2024cites this paper
• Levels of Asymmetric Dimethylar Ginine and Risk of Neurovascular Diseases: A Systematic Review and Meta‐Analysis

  2024cites this paper
• Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial

  2023cites this paper
• Molecular biomarkers for vascular cognitive impairment and dementia

  2023cites this paper
• Epigenetic and integrative cross-omics analyses of cerebral white matter hyperintensities on MRI

  2022cites this paper
• Advances in the Role of Endothelial Cells in Cerebral Small Vessel Disease

  2022cites this paper
• L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older Adults

  2022cites this paper
• Arginine and Endothelial Function

  2020cites this paper
• Endothelial Dysfunction May Link Interatrial Septal Abnormalities and MTHFR-Inherited Defects to Cryptogenic Stroke Predisposition

  2020cites this paper
• ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease

  2019cites this paper
• Serum homocysteine level is related to cerebral small vessel disease in a healthy population

  2019cites this paper
• Young rats with increased circulatory asymmetric dimethylarginine exhibited spatial deficit and alterations in dorsal hippocampus brain‐derived neurotrophic factor and asymmetric dimethylarginine: Effects of melatonin

  2019cites this paper
• Melatonin prevented spatial deficits and increases in brain asymmetric dimethylarginine in young bile duct ligation rats

  2018cites this paper
• Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies

  2018cites this paper
• Markers of endothelial function and progression of cerebral small vessel disease: A longitudinal MR Imaging study

  2018cites this paper
• Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review

  2016cites this paper
• The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood–brain barrier in vitro

  2016cites this paper
• Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.

  2015cites this paper
• The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome.

  2014cites this paper
• Increased Circulatory Asymmetric Dimethylarginine and Multiple Organ Failure: Bile Duct Ligation in Rat as a Model

  2014cites this paper
• The role of L-arginine and methylated-arginines in health and disease

  2014cites this paper
• Resting Brain Perfusion and Selected Vascular Risk Factors in Healthy Elderly Subjects

  2014cites this paper
• Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?

  2013cites this paper
• The pathobiology of vascular dementia.

  2013cites this paper
• Interactions of endogenous and exogenous molecules with the human blood-brain barrier

  2012influential citation
• Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease

  2012cites this paper
• Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke

  2012cites this paper
• Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus

  2011cites this paper
• Endothelial Dysfunction of the Peripheral Vascular Bed in the Acute Phase after Ischemic Stroke

  2011cites this paper
• Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus

  2010cites this paper
• ADMA and the brain: an unfolding story.

  2009cites this paper
• ГОМОЦИСТЕИН: РОЛЬ В РАЗВИТИИ И ПРОГРЕССИРОВАНИИ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК HOMOCYSTEINE: ROLE IN THE DEVELOPMENT AND PROGRESSION OF CHRONIC RENAL DISEASE

  year unknowncites this paper